H. Fox

University of Geneva (CH)

Research Areas

Discover Papers by H. Fox

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

152

Publications

2140

Citations

132070

i10-index

1539

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Benefits of omalizumab as add‐on therapy in patien...	2004	1114
The anti-IgE antibody omalizumab reduces exacerbat...	2001	826
A new measurement of direct CP violation in two pi...	1999	320
Omalizumab provides long-term control in patients ...	2002	180
The anti-IgE antibody omalizumab improves asthma-r...	2002	158
The barrel modules of the ATLAS semiconductor trac...	2006	152
Inhaled dry powder mannitol in cystic fibrosis: an...	2011	151
Safety of anti‐immunoglobulin E therapy with omali...	2007	134
The ATLAS semiconductor tracker end-cap module	2007	101
The silicon microstrip sensors of the ATLAS semico...	2007	99

Publications

1.
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Year: 2004Citations: 1114DOI: 10.1111/j.1398-9995.2004.00772.x
2.
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
Year: 2001Citations: 826DOI: 10.1183/09031936.01.00092101
3.
A new measurement of direct CP violation in two pion decays of the neutral kaon
Year: 1999Citations: 320DOI: 10.1016/s0370-2693(99)01030-8
4.
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
Year: 2002Citations: 180DOI: 10.1183/09031936.02.00278102
5.
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
Year: 2002Citations: 158DOI: 10.1183/09031936.02.00016502
6.
The barrel modules of the ATLAS semiconductor tracker
Year: 2006Citations: 152DOI: 10.1016/j.nima.2006.08.036
7.
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
Year: 2011Citations: 151DOI: 10.1183/09031936.00187510
8.
Safety of anti‐immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
Year: 2007Citations: 134DOI: 10.1111/j.1365-2222.2007.02650.x
9.
The ATLAS semiconductor tracker end-cap module
Year: 2007Citations: 101DOI: 10.1016/j.nima.2007.02.019
10.
The silicon microstrip sensors of the ATLAS semiconductor tracker
Year: 2007Citations: 99DOI: 10.1016/j.nima.2007.04.157

About H. Fox

H. Fox is a researcher with 2140 publications and 132070 citations. They are affiliated with University of Geneva. Their research focuses on . With an h-index of 152, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from H. Fox and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year